United Therapeutics filed required documents for executive stock transactions and listed its stock on the exchange.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
United Therapeutics filed required documents for executive stock transactions and listed its stock on the exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- United Therapeutics disclosed stock sales by CEO Martine Rothblatt via required SEC filing.Sub-event
United Therapeutics lists stock and files required executive transaction documents.1 source
Keep exploring
Part of
Filing requirements governing market operations are in effect, involving Nasdaq and the SEC.Also in this story
- BTQ Technologies Corp. lists its shares on the Nasdaq market after filing its prospectus with Canadian authorities and registration statements with the SEC.
- AIRO Group traded shares on the electronic stock exchange and filed required documents with the SEC.
- Kearny Financial stock is listed on Nasdaq, and an acquisition has been disclosed in documents filed with the SEC.
The entities involved
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
- Various financial institutions, including Royal Bank of Canada, Bank of America, Raymond James Financial, TD Cowen, Cantor Fitzgerald, and MarketBeat, issued rating and price target updates regarding United Therapeutics on July 10, 2026.
- Paul A. Mahon was named EVP and General Counsel at United Therapeutics.
-
SEC
Slovak company